Search - tctmd.com

Displaying 41 - 60 of 808

Sort: Relevancy | Date

Presentation TCT 2025

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Hasan Ilyas

October 26, 2025

Presentation TCT 2025

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mostafa Ali

October 26, 2025

Presentation TCT 2025

TCT 1455: When MAC Attacks: Stroke-Driven Discovery and Percutaneous Removal of a Mobile Mitral Annular Mass via Transseptal AngioVac With Cerebral Protection

Presenter: Huseyin Emre Arman

October 26, 2025

Presentation TCT 2025

TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes

Presenter: Rakendu Jayasree Rajendran

October 25, 2025

Presentation TCT 2025

TCT 822: Prognostic Implications of Forward Stroke Volume Index After Mitral Transcatheter Edge-to-Edge Repair in Patients With Ventricular Functional Mitral Regurgitation

Presenter: Masafumi Yoshikawa

October 25, 2025

Presentation TCT 2025

ARS 1: The Art of Disruptive Innovation: Process or the Stroke of Genius

Presenter: Andrew D. Cleeland

October 25, 2025

Presentation ESC 2025

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

Presenter: Jonas Oldgren

August 30, 2025

Presentation TCT India 2025

Embolic Protection in TAVR: Present Status and Future

Presenter: Samir Kapadia

July 27, 2025

Presentation TCT India 2025

Acute Stroke Interventions – Newer Improvements

Presenter: Anshu Mahajan

July 26, 2025

Presentation NY Valves 2025

Sentinel Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

June 27, 2025

Presentation NY Valves 2025

Impact of Prior History of Stroke on Clinical Outcomes in Patients With Severe Aortic Stenosis Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 27, 2025

Presentation NY Valves 2025

Quantification of Debris Captured Using Transcatheter Cerebral Embolic Protection During Valve in Valve Transcatheter Aortic Valve Replacement With Bioprosthetic Valve Fracture

Presenter: Adnan K. Chhatriwalla

June 27, 2025

Presentation NY Valves 2025

Anatomic Correlation Between Noninvasive and Invasive Angiogram on the Use of Cerebral Embolic Protection Devices in TAVR: A Real-world Experience From a Single Tertiary Care Center

Presenter: Bhavanadhar Penta

June 27, 2025

Presentation NY Valves 2025

My Patient Has Severe Primary MR, Symptomatic AF, and is at High Risk for Stroke and Bleeding: How Do I Time M-TEER and LAAO/Ablation?

Presenter: Matthew J. Price

June 26, 2025

Presentation NY Valves 2025

Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice

Presenter: Alexandra J. Lansky

June 26, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Presenter: Jerry Lipinski

October 30, 2024

Advertisement

TCT 322: Routine Use of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 321: Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials

TCT 1455: When MAC Attacks: Stroke-Driven Discovery and Percutaneous Removal of a Mobile Mitral Annular Mass via Transseptal AngioVac With Cerebral Protection

TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes

TCT 822: Prognostic Implications of Forward Stroke Volume Index After Mitral Transcatheter Edge-to-Edge Repair in Patients With Ventricular Functional Mitral Regurgitation

ARS 1: The Art of Disruptive Innovation: Process or the Stroke of Genius

ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation

Embolic Protection in TAVR: Present Status and Future

Acute Stroke Interventions – Newer Improvements

Sentinel Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis of Randomized Controlled Trials

Impact of Prior History of Stroke on Clinical Outcomes in Patients With Severe Aortic Stenosis Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Quantification of Debris Captured Using Transcatheter Cerebral Embolic Protection During Valve in Valve Transcatheter Aortic Valve Replacement With Bioprosthetic Valve Fracture

Anatomic Correlation Between Noninvasive and Invasive Angiogram on the Use of Cerebral Embolic Protection Devices in TAVR: A Real-world Experience From a Single Tertiary Care Center

My Patient Has Severe Primary MR, Symptomatic AF, and is at High Risk for Stroke and Bleeding: How Do I Time M-TEER and LAAO/Ablation?

Stroke and Cerebral Embolic Protection Devices in Contemporary TAVR Practice

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

TCT 846: Association of Cerebral Embolic Protection Device Use With Disabling Stroke After Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content